Charles Gore, chief executive of the
Hepatitis C Trust, said the disease could be eradicated in the next 30 years or so if the Government committed to increasing diagnosis, stopping further transmission of the disease and offering high quality treatment and care.
The hepatitis C (HCV) market is expected to become one of the fastest growing markets in Pharma over the next decade given a sizable 170 million patient population, a significant unmet need and rapid advancements in the clinic.
Methodology This report provides a qualitative overview of the current and future Hepatitis C (HCV) market.
Those at increased risk for
hepatitis C infection should also be tested, including people who ever injected illegal drugs (even if they did so only once or many years ago), have abnormal liver tests, received donated blood or organs before 1992, have been exposed to blood at work through needle sticks or injury with a sharp object, or were ever on hemodialysis.
The ability of a patient to be tested and treated for
hepatitis C at the earliest possible date allows him or her to get treated and avoid the
hepatitis C's progression to liver cancer.
